Non-ownership Filings
| Update on anselamimab in AL amyloidosis | Jul. 16, 2025 |
| Baxdrostat met primary endpt in BaxHTN PhIII trial | Jul. 14, 2025 |
| Imfinzi approved in the EU for bladder cancer | Jul. 04, 2025 |
| Total Voting Rights | Jul. 01, 2025 |
| Datroway approved in US for EGFRm lung cancer | Jun. 24, 2025 |
| AstraZeneca enters into collaboration with CSPC | Jun. 13, 2025 |
| Block listing Interim Review | Jun. 02, 2025 |
Ownership Update Filings
| Director/PDMR Shareholding | Jun. 12, 2025 |
| Director/PDMR Shareholding | May. 23, 2025 |
| Director/PDMR Shareholding | May. 01, 2025 |
| Holding(s) in Company | Mar. 12, 2025 |
| Director/PDMR Shareholding | Mar. 07, 2025 |
| Director/PDMR Shareholding | Mar. 06, 2025 |
| Director/PDMR Shareholding | Mar. 05, 2025 |